Building a Substitute Pancreas for Diabetics

/Building a Substitute Pancreas for Diabetics

 MIT Technology Review, Emily Singer. June 28, 2010:  A startup hopes implanted insulin-producing cells will free diabetics from insulin injections. Implants containing specially wrapped insulin-producing cells derived from embryonic stem cells can regulate blood sugar in mice for several months, according to research presented this month at the International Society for Stem Cell Research conference in San Francisco. San Diego-based ViaCyte (formerly Novocell), which is developing the implant as a treatment for type 1 diabetes, is now beginning the safety testing required for approval from the U.S. Food and Drug Administration before human testing can start. Read entire article »